Biologics and parenteral drug products require highly reliable packaging systems to maintain sterility and product stability throughout their lifecycle. Unlike traditional pharmaceutical products, biologics are highly sensitive to contamination, moisture, oxygen exposure, and temperature changes. Even a very small leak in the packaging system can affect product quality and patient safety.
As injectable therapies, vaccines, and advanced biologics continue to grow, Container Closure Integrity Testing (CCIT) has become an important part of pharmaceutical quality assurance. Manufacturers now require testing methods that are accurate, repeatable, and highly sensitive. Helium leak detection has become one of the most effective deterministic technologies for this purpose.
Why CCI Testing Is Important for Biologics?
Container Closure Integrity Testing helps ensure that sterile pharmaceutical products remain protected during storage, transportation, and distribution.
Key Benefits of CCIT
- Protects biologics from contamination and moisture.
- Maintains product sterility and stability.
- Supports regulatory compliance requirements.
- Extends product shelf life.
- Reduces risk to patient safety.
Traditional testing methods such as dye ingress and microbial testing may not always detect extremely small leaks. Modern biologic packaging systems require more sensitive and quantitative testing methods.
Helium Leak Detection
Helium Leak Detection (HLD) is a highly sensitive method used to identify microscopic leaks in pharmaceutical packaging systems. Helium is used as a tracer gas because it is small, inert, and safe for pharmaceutical applications.
Why Helium is Used ?
- Helium can pass through extremely small leak paths.
- It helps detect microleaks other methods may miss.
- Helium is non-reactive and does not affect products or packaging.
- Low atmospheric background improves testing accuracy.
The technology uses mass spectrometry to measure helium flow through a package defect. Unlike traditional leak testing methods, helium leak detection provides direct and quantitative leak rate measurement.
With sensitivity levels as low as 1×10?¹² l/s, helium leak testing can identify extremely small leaks that may impact sterility over time.
SIMS 1915+ for Pharmaceutical Leak Testing
The SIMS 1915+ is designed for deterministic helium leak testing in pharmaceutical and biologic packaging applications.
The system supports testing for:
- Vials
- Prefilled syringes
- Cartridges
- Combination products
SIMS 1915+ directly measures active leak rates and can detect sub-micron defects that conventional methods may miss. The system supports package development, validation, stability studies, and quality assurance programs.
It is also suitable for temperature-sensitive biologics and can support testing under cold and ultra-cold storage conditions.
High-Sensitivity Detection of Sub-Micron Leaks
Advanced helium leak detection systems can identify extremely small defects that are difficult to detect using visual inspection or traditional testing methods.
Even tiny leaks can allow gas, moisture, or microbial ingress over time, potentially affecting product sterility and stability. Helium leak testing helps manufacturers identify these defects early and improve package reliability.
Conclusion
As biologics and parenteral therapies become more advanced, reliable package integrity testing is increasingly important. Traditional testing methods may not provide the sensitivity needed for modern pharmaceutical packaging systems.
Helium leak detection provides a highly sensitive and quantitative approach to evaluating container closure integrity. Advanced systems such as the SIMS 1915+ help manufacturers improve package quality, support regulatory compliance, and protect patient safety.
